Back to browse

The endosomal escape vehicle platform enhances delivery of oligonucleotides in preclinical models of neuromuscular disorders

Paper ID

PAPER000211

Year

2023

DOI

10.1016/j.omtn.2023.06.022

PMID

37538053

Journal

Molecular Therapy - Nucleic Acids

Source URL

Experiments

• EXP001252 with EEV1 (PMO (antisense oligonucleotide))
• EXP001253 with EEV2 (PMO (antisense oligonucleotide))
• EXP001254 with EEV1 (PMO (antisense oligonucleotide))
• EXP001255 with EEV1 (PMO (antisense oligonucleotide))
• EXP001256 with EEV1 (PMO (antisense oligonucleotide))
• EXP001257 with EEV1 (PMO (antisense oligonucleotide))
• EXP001258 with EEV1 (PMO (antisense oligonucleotide))
• EXP001259 with EEV2 (PMO (antisense oligonucleotide))
• EXP001260 with EEV2 (PMO (antisense oligonucleotide))
• EXP001261 with EEV2 (PMO (antisense oligonucleotide))
• EXP001262 with EEV2 (PMO (antisense oligonucleotide))